A functional screening identifies five micrornas controlling glypican-3: Role of mir-1271 down-regulation in hepatocellular carcinoma

Hepatology

Volumn 57, Issue 1, 2013, Pages 195-204

  Maurel, Marion ^a   Jalvy, Sandra ^a   Ladeiro, Yannick ^b,c   Combe, Chantal ^a   Vachet, Laetitia ^a   Sagliocco, Francis ^a   Bioulac Sage, Paulette ^a   Pitard, Vincent ^d,e   Jacquemin Sablon, Hélène ^a   Zucman Rossi, Jessica ^b,c   Laloo, Benoît ^a   Grosset, Christophe F ^a  

^a U1053 ^*  (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d CNRS Bordeaux Segalen University   (France)

^e CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYPICAN 3; MESSENGER RNA; MICRORNA; MICRORNA 1271; MICRORNA 1291; MICRORNA 1291 3P; MICRORNA 1303; MICRORNA 96; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CANCER SCREENING; CANCER TISSUE; CARCINOMA CELL; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; GENE REPRESSION; GROWTH INHIBITION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER; LIVER CELL; LIVER CELL CARCINOMA; LIVER SURGERY; MAJOR CLINICAL STUDY; MOLECULAR LIBRARY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION;

3' UNTRANSLATED REGIONS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYPICANS; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MICRORNAS; RNA PROCESSING, POST-TRANSCRIPTIONAL;

EID: 84872128718     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25994     Document Type: Article

References (32)

1. Jain S, Singhal S, Lee P, Xu R. Molecular genetics of hepatocellular neoplasia. Am J Transl Res 2010; 2: 105-118.
2. Nault JC, Zucman-Rossi J. Genetics of hepatobiliary carcinogenesis. Semin Liver Dis 2011; 31: 173-187.
3. Hoshida Y, Toffanin S, Lachenmayer A, Villanueva A, Minguez B, Llovet JM. Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin Liver Dis 2010; 30: 35-51.
4. Boyault S, Rickman DS, de Reynies A, Balabaud C, Rebouissou S, Jeannot E, et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. HEPATOLOGY 2007; 45: 42-52.
5. Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, Jaeger SA, et al. An HNF4alpha-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 2011; 147: 1233-1247.
6. Ho M, Kim H. Glypican-3: a new target for cancer immunotherapy. Eur J Cancer 2011; 47: 333-338.
7. Allegretta M, Filmus J. Therapeutic potential of targeting glypican-3 in hepatocellular carcinoma. Anticancer Agents Med Chem 2011; 11: 543-548.
8. Hoshida Y, Nijman SM, Kobayashi M, Chan JA, Brunet JP, Chiang DY, et al. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res 2009; 69: 7385-7392.
9. Shirakawa H, Suzuki H, Shimomura M, Kojima M, Gotohda N, Takahashi S, et al. Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma. Cancer Sci 2009; 100: 1403-1407.
10. Sotiropoulou G, Pampalakis G, Lianidou E, Mourelatos Z. Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. RNA 2009; 15: 1443-1461.
11. Huang S, He X. The role of microRNAs in liver cancer progression. Br J Cancer 2011; 104: 235-240.
12. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010; 11: 597-610.
13. Laloo B, Simon D, Veillat V, Lauzel D, Guyonnet-Duperat V, Moreau-Gaudry F, et al. Analysis of post-transcriptional regulations by a functional, integrated, and quantitative method. Mol Cell Proteomics 2009; 8: 1777-1788.
14. Breving K, Esquela-Kerscher A. The complexities of microRNA regulation: mirandering around the rules. Int J Biochem Cell Biol 2010; 42: 1316-1329.
15. Wahid F, Shehzad A, Khan T, Kim YY. MicroRNAs: synthesis, mechanism, function, and recent clinical trials. Biochim Biophys Acta 2010; 1803: 1231-1243.
16. Laloo B, Maurel M, Jalvy-Delvaille S, Sagliocco F, Grosset CF. Analysis of post-transcriptional regulation using the FunREG method. Biochem Soc Trans 2010; 38: 1608-1614.
17. Simon D, Laloo B, Barillot M, Barnetche T, Blanchard C, Rooryck C, et al. A mutation in the 3′-UTR of the HDAC6 gene abolishing the post-transcriptional regulation mediated by hsa-miR-433 is linked to a new form of dominant X-linked chondrodysplasia. Hum Mol Genet 2010; 19: 2015-2027.
18. Jalvy-Delvaille S, Maurel M, Majo V, Pierre N, Chabas S, Combe C, et al. Molecular basis of differential target regulation by miR-96 and miR-182: the Glypican-3 as a model. Nucleic Acids Res 2012; 40: 1356-1365.
19. Peter ME. Targeting of mRNAs by multiple miRNAs: the next step. Oncogene 2010; 29: 2161-2164.
20. Thomson DW, Bracken CP, Goodall GJ. Experimental strategies for microRNA target identification. Nucleic Acids Res 2011; 39: 6845-6853.
21. Dweep H, Sticht C, Pandey P, Gretz N. miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform 2011; 44: 839-847.
22. Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. HEPATOLOGY 2008; 47: 1955-1963.
23. Jensen KP, Covault J. Human miR-1271 is a miR-96 paralog with distinct non-conserved brain expression pattern. Nucleic Acids Res 2011; 39: 701-711.
24. Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T, Hammond SM. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 2006; 20: 2202-2207.
25. Slezak-Prochazka I, Durmus S, Kroesen BJ, van den Berg A. MicroRNAs, macrocontrol: regulation of miRNA processing. RNA 2010; 16: 1087-1095.
26. Jiang Q, Feng MG, Mo YY. Systematic validation of predicted microRNAs for cyclin D1. BMC Cancer 2009; 9: 194.
27. Wu S, Huang S, Ding J, Zhao Y, Liang L, Liu T, et al. Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region. Oncogene 2010; 29: 2302-2308.
28. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008; 455: 58-63.
29. Bentwich I. Prediction and validation of microRNAs and their targets. FEBS Lett 2005; 579: 5904-5910.
30. Yamanaka S, Olaru AV, An F, Luvsanjav D, Jin Z, Agarwal R, et al. MicroRNA-21 inhibits Serpini1, a gene with novel tumor suppressive effects in gastric cancer. Dig Liver Dis 2012; 44: 589-596.
31. Yu S, Lu Z, Liu C, Meng Y, Ma Y, Zhao W, et al. miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer. Cancer Res 2010; 70: 6015-6025.
32. Nurul-Syakima AM, Yoke-Kqueen C, Sabariah AR, Shiran MS, Singh A, Learn-Han L. Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers. Int J Mol Med 2011; 28: 327-336.